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REGULATORY AGENCY ACTION
release of contact lenses; rather, when
the optometrist elects to release a pre-
scription, it merely requires him/her to
issue a complete prescription so the con-
sumer may have it filled without having
to be refit. In the end, the Board took no
action on proposed section 1570; at
some time in the future, the Regulation
Committee will attempt to redraft the
language to clarify the Board's intent.
The Board also considered an
amendment of section 1502 of its regu-
lations, which would delegate to the
Executive Officer specified powers and
duties conferred by law on the Board.
These powers and duties include the
duty to receive and file accusations;
issue notices of hearing and statements
of issues; issue subpoenas; set and cal-
endar cases for hearing; and other func-
tions necessary to the businesslike dis-
patch of the business of the Board. This
type of delegation of authority is stan-
dard operating procedure at almost all
other agencies; Board legal counsel
Robert Miller explained that the ratio-
nale underlying the delegation of
authority is that a non-Board member
should be the one to decide to bring dis-
ciplinary action and file accusations,
reserving for the Board the ultimate
decisionmaking authority.
COA and Pearle, Inc. opposed this
proposed amendment. Both expressed
concern that the Board would be "taken
out of the loop." However, the Board
adopted the amendment following the
hearing; the rulemaking file still awaits
review by the Office of Administrative
Law (OAL).
Next, the Board considered an
amendment to section 1510, which
would state that the failure of an
optometrist to inform the patient of the
risks and benefits of the treatment pre-
scribed and all alternative viable modes
of treatment constitutes professional
inefficiency. The Board decided not to
adopt this amendment.
Finally, the Board considered the
repeal of section 1535. The repeal
would permit applicants for examination
for licensure to take the Board's exami-
nation prior to successful completion of
the National Board Examination in
Optometry. (See CRLR Vol. 10, No. I
(Winter 1990) p. 87 for background
information.) The Board took no action
on this proposed regulatory change.
LEGISLATION:
AB 1462 (Klehs), as amended June
13, would require a health care service
plan that provides one or more optomet-
ric services to provide an enrollee of the
plan the opportunity to receive a com-
prehensive optometric examination, and
would prohibit the plan from scheduling
an examination for fewer than thirty
minutes unless the optometrist deter-
mines in his/her professional judgment
that the examination may be satisfactori-
ly completed in fewer than thirty min-
utes. This bill is pending in the Senate
Committee on Insurance, Claims and
Corporations.
The following is a status update of
bills described in detail in CRLR Vol.
10, No. 1 (Winter 1990) at page 88:
AB 2114 (Bane), which would have
affected optometric examination qualifi-
cations, was dropped and reintroduced
as AB 3129, which has died in commit-
tee.
AB 2198 (Klehs), as amended March
12, would require the Board to hold
licensure examinations at least twice per
year until January 1, 1994. This bill
would state the intent of the legislature
that the Board's examination be self-
supporting, and would limit the use of
examination fees to specified activities.
This bill is pending in the Senate
Business and Professions Committee.
AB 881 (Hughes), which would
authorize the Board to require proof of
completion of continuing education as a
condition for license renewal, is still
pending in the Senate inactive file.
SB 929 (Seymour), which would
have affected mail order contact lenses,
was substantially amended and no
longer relates to optometry.
SB 1104 (Roberti). Under Business
and Professions Code section 3057.5,
the Board, for purposes of licensure in
optometry, may refuse to honor a doctor
of optometry degree awarded by a for-
eign university if the Board determines
its instruction is not equivalent to that
offered at colleges and universities in
the United States; that authority ends on
January 1, 1991, pursuant to the terms
of SB 1347 (Roberti) (Chapter 1473,
Statutes of 1987). As amended June 21,
this bill would extend that authority
until January 1, 1994. SB 1104 is pend-
ing in the Assembly Ways and Means
Committee.
LITIGATION:
On May 10, the U.S. Court of
Appeals for the District of Columbia
Circuit heard oral argument in
California State Board of Optometry v.
Federal Trade Commission, No. 89-
1190, regarding the validity of the
FTC's "Eyeglasses II" regulation, which
would prevent state boards of optometry
from prohibiting what has come to be
called "corporate optometry." A deci-
sion is expected by September 1990.
(See CRLR Vol. 10, No. 1 (Winter
1990) pp. 88-89 for extensive back-
ground information on this issue.)
FUTURE MEETINGS:
August 13-14 in Sacramento.





Pursuant to Business and Professions
Code section 4000 et seq., the Board of
Pharmacy grants licenses and permits to
pharmacists, pharmacies, drug manufac-
turers, wholesalers and sellers of hypo-
dermic needles. It regulates all sales of
dangerous drugs, controlled substances
and poisons. The Board is authorized to
adopt regulations, which are codified in
Chapter 17, Title 16 of the California
Code of Regulations (CCR). To enforce
its regulations, the Board employs full-
time inspectors who investigate accusa-
tions and complaints received by the
Board. Investigations may be conducted
openly or covertly as the situation
demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, includ-
ing professional misconduct and any
acts substantially related to the practice
of pharmacy.
The Board consists of ten members,
three of whom are public. The remain-
ing members are pharmacists, five of
whom must be active practitioners. All
are appointed for four-year terms.
MAJOR PROJECTS:
Regulatory Changes. The Board's
regulatory program has had little suc-
cess in the Office of Administrative Law
(OAL) in the past several months.
Although OAL, on January 18,
approved the Board's new section 1710,
which defines the term "inpatient hospi-
tal pharmacy" (see CRLR Vol. 9, No. 4
(Fall 1989) p. 75 for background infor-
mation), it then proceeded to reject
numerous regulatory packages.
-Foreign Graduates. Following an
October 25 public hearing, the Board
adopted new section 1720.1, which sets
forth the criteria used by the Board in
determining whether to authorize gradu-
ates of foreign pharmacy schools to take
the pharmacist registration examination.
The Board also added subsections (c)
and (d) to section 1720, and amended
existing section 1720(b); these changes
provide specific time periods within
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which applicants for the examination
and applicants for registration must
complete each application process. (See
CRLR Vol. 10, No. I (Winter 1990) p.
90 and Vol. 9, No. 4 (Fall 1989) p. 75
for background information.) On
January 19, OAL rejected the package,
on grounds that it failed to comply with
the necessity, clarity, and consistency
requirements in Government Code sec-
tion 11349.1. The Board subsequently
modified these sections and resubmitted
them to OAL, which approved them on
June 18.
-"Black Bag" Regulation. Also on
October 25, the Board approved the pro-
posed addition of new section 1751.10,
which allows a pharmacist to carry and
furnish, to a patient at home, dangerous
drugs (except controlled substances) and
devices for parenteral therapy (the intra-
venous administration of medication)
when the dangerous drug or device is
one currently prescribed for the patient,
and the prescription has not been super-
seded by a different drug or device.
OAL rejected that provision on January
8, concluding that the Board failed to
demonstrate necessity and that it failed
to comply with specified technical
requirements of the Administrative
Procedure Act (APA). The Board cor-
rected the errors and resubmitted the
provision; OAL approved it on June 15.
-Ancillary Personnel. On March 1,
OAL rejected for a second time the
Board's amendment to section 1717,
which specifies the tasks which may be
performed by an unlicensed person
under the supervision of a licensed phar-
macist. (See CRLR Vol. 10, No. 1
(Winter 1990) p. 90 and Vol. 9, No. 4
(Fall 1989) p. 75 for background infor-
mation.) OAL rejected this regulatory
change primarily on grounds that it is
inconsistent with numerous sections of
the Business and Professions Code,
which specify that only a licensed phar-
macist may "dispense" drugs. OAL has
trouble with several "packaging tasks"
which the new rule would authorize
unlicensed personnel to perform; it
believes that these "packaging tasks"
may be part of "dispensing" and are
therefore non-delegable to persons who
are not registered pharmacists or statuto-
ry exemptees. The Board strongly dis-
agrees with OAL's interpretation; it
plans to resubmit section 1717, but if
OAL rejects it again, the Board plans to
appeal to the Governor's office.
-Oral Consultation. On March 9,
OAL rejected for a second time the
Board's amendment of section 1707.1,
which would require pharmacists to
maintain patient medication profiles for
all ongoing patient-consumers, and to
provide an oral consultation to each
patient or patient's agent, with specified
exceptions. (See CRLR Vol. 10, No. I
(Winter 1990) p. 90 and Vol. 9, No. 4
(Fall 1989) p. 75 for background infor-
mation.) This time, OAL rejected the
regulatory package on clarity grounds;
also, the Board failed to fully summa-
rize and respond to all public comments
on the proposed change, and to comply
with all procedural requirements of the
APA. The Board modified the language
of the proposal and published it for a fif-
teen-day comment period which ended
on May 19; at this writing, the Board is
preparing the rulemaking package for
resubmission to OAL.
-English Proficiency Examination.
On April 18, OAL rejected the Board's
amendment of section 1719, which
would require that candidates for licen-
sure who have been non-U.S. residents
for more than ten years to take and pass
the Test of Spoken English in addition to
satisfying all other licensure require-
ments. OAL found that the proposed
regulation failed to satisfy the clarity
and necessity standards, and that the
Board failed to comply with the proce-
dural requirements of the APA. The
Board plans to modify the language of
section 1719, publish it for a fifteen-day
comment period, and resubmit the sec-
tion to OAL.
Preprinted Prescription Pads. At its
January 31 and March 28 meetings, the
Board continued its discussion of draft
regulatory section 1717.3, \which would
define a "preprinted, multiple check-off
prescription blank" and the permissible
ways in which these may be used. At its
March meeting, the Board approved
draft language, and was scheduled to
hold a May 31 hearing on the proposal,
which would prohibit pharmacists (1)
from dispensing any controlled sub-
stances on such preprinted blanks; and
(2) from dispensing more than one dan-
gerous drug from such a preprinted
blank. (See CRLR Vol. 10, No. 1
(Winter 1990) pp. 90-91 for background
information.)
Attorney General's Opinion. On
April 18, the Attorney General's Office
issued Opinion No. 89-1101, in response
to a request by former Executive Officer
Lorie Rice. The AG offered an interpre-
tation of section 4046(c)(1) of the
Business and Professions Code, which
provides that neither the California
Pharmacy Law nor any other law shall
be construed to prohibit a registered
pharmacist from furnishing to a pre-
scriber a reasonable quantity of com-
pounded medication for prescriber
office use. The following terms were
interpreted:
(1) "Reasonable quantity" means the
amount of medication an ordinarily pru-
dent pharmacist would believe likely to
be used or dispensed by a physician in
the particular circumstances of that
physician, based on all the facts known
to or which should reasonably be known
to the pharmacist.
(2) "Compounded medication" does
not include medication which the phar-
macy repackages but does not reformu-
late or admix.
(3) "Prescriber office use" includes
drugs which the prescriber dispenses to
patients for administration outside the
prescriber's office or clinic.
Dispensing by Emergency Room
Physicians. At its January meeting, the
Board adopted the following guidelines
concerning the distribution of
prescription medication by emergency
room physicians. First, if medication is
required after the pharmacist's business
hours, an emergency room physician
may distribute up to three doses of med-
ication if it is properly labeled and is
accompanied by a prescription. Second,
an emergency room physician may dis-
tribute a full course of drug treatment if
the medication is from the physician's
personal stock and he/she complies with
section 4051 of the Business and
Professions Code. Third, an emergency
room physician may dispense a full
course of drug treatment if the patient's
physician calls the emergency room
physician and requests that the physi-
cian on duty dispense the medication.
However, the physician on duty must
examine the patient before he/she dis-
tributes the medication.
LEGISLATION:
AB 4168 (Hunter), as amended June
11, would require the Director of the
Department of Health Services (DHS) to
rely on drug product research, testing,
information and formularies compiled
by other states and other sources, as
specified, when compiling the formulary
of generic drug types and products that
may pose a threat to the health and safe-
ty of patients receiving medication, if
that medication is substituted by a phar-
macist in lieu of a brand name drug pre-
scribed by a prescriber. The bill would
require that the formulary be mailed to
in-state pharmacists. Under the bill,
products listed as "Code A" in a speci-
fied publication issued by the U.S.
Department of Health and Human
Services could be substituted by phar-
macists; if the drug product is designat-
ed as "Code B" in that publication, the
pharmacist would be prohibited from
substituting for the product unless
he/she obtains permission from the
physician. This bill is pending in the
Senate Health and Human Services
Committee.
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SB 736 (Marks), as amended April 5,
would require DHS to approve senior
citizen medication education programs
over the period July 1, 1991 to June 30,
1992 in up to six local health jurisdic-
tions which have applied for funding
under the bill, which would also set
forth mandatory program components. It
would also require DHS to report by
December 31, 1992 to the legislature on
effectiveness of the provisions of the
bill, which is currently pending in the
Assembly Ways and Means Committee.
AB 2064 Clute) makes it a misde-
meanor to advertise the sale of anabolic
steroids, unless the advertisement also
states that possession or sale to an ulti-
mate consumer is a crime punishable by
a substantial fine and imprisonment.
This bill was signed by the Governor on
April 30 (Chapter 67, Statutes of 1990).
AB 3276 (Bronzan), as amended May
2, would require a pharmacist to attach a
label or enclosure to the drug container
whenever a prescribed drug has not
been previously dispensed to the patient,
or whenever the prescribed drug has
been dispensed in a different dosage,
form, strength, or with different written
directions. This bill is currently pending
in the Senate Business and Professions
Committee.
AB 3975 (Margolin), as amended
June 6, would require the Board to des-
ignate a statewide drug information cen-
ter to provide direct telephone assistance
or referral to appropriate health care
providers for any person desiring infor-
mation relating to prescription drugs.
The bill would provide for a voluntary
contribution check-off on the form for
the renewal of a nongovernmental phar-
macy and a pharmacist's license, and
would increase the renewal fee for an
out-of-state distributor's license; and
would provide for the deposit of that
increased fee money into the Drug
Information Account to be created by
this bill. This bill is pending in the
Senate Business and Professions
Committee.
AB 4106 (Polanco), as amended May
7, would provide that a person exempt
from the Pharmacy Licensing Law must
be present any time a person is seeking
a fitting or consultation on a medical
device, except that an exemptee need
not be present if the dangerous devices
are stored in a secure locked area as
specified. The bill would also provide
that pharmacists are not prohibited from
performing certain procedures or func-
tions involving nonlegend medical
devices. This bill is pending in the
Senate Business and Professions
Committee.
SB 1829 (Watson), as amended May
1, would authorize DHS to authorize a
pilot project in the City and County of
San Francisco. Under the project, when
it is determined that a disease is life
threatening and the spread is substantial,
the local health officer would be autho-
rized to take all measures that the officer
deems appropriate to prevent the further
spread of the disease. This bill would
require a local health officer who devel-
ops new innovative programs, or under-
takes new measures to prevent the fur-
ther spread of disease, to establish pro-
tocols approved by DHS, and to annual-
ly report to the legislature and DHS on
specified aspects of that action. The bill
would express legislative intent, and the
provisions would be operative for
twelve months from the date DHS
approves the pilot program. This bill is
currently pending in the Senate inactive
file.
AB 2713 (Moore), as amended April
30, would require manufacturers of non-
prescription drugs sold in California to
evaluate, and permit them to modify, the
labeling of nonprescription drugs to
maximize the readability and clarity of
label information, in both the cognitive
and visual sense. The Nonprescription
Drug Manufacturers Association would
be required to report on a quarterly basis
to and seek advice periodically from
DHS and an advisory committee
appointed by the DHS Director regard-
ing the progress made by the nonpre-
scription drug industry with respect to
the readability and clarity of labeling
information. This bill is pending in the
Senate Committee on Health and
Human Services.
SB 2827 (Roberti), as amended April
26, would require the Board to encour-
age every licensed pharmacist to take a
course in geriatric pharmacology as part
of his/her continuing education require-
ments. This bill is pending in the
Assembly Health Committee.
The following is a status report on
bills discussed in CRLR Vol. 10, No. I
(Winter 1990) at page 91:
AB 1006 (Isenberg), as amended
May 14, would require a health care ser-
vice plan or a nonprofit hospital service
plan to give written notice to all phar-
macy providers in their service area of
their intent to contract for, or change the
manner of payment for, the delivery of
pharmacy services, and to give those
providers an opportunity to submit a bid
to participate in the plan's panel of
providers. The bill is currently pending
in the Senate Committee on Insurance,
Claims and Corporations.
AB 1177 (Kelley) would require a
pharmacist to inform a patient either
orally or in writing of the harmful
effects of a drug dispensed by prescrip-
tion, if the drug poses substantial risk
when taken in combination with other
prescribed drugs known to the pharma-
cist as having been dispensed to that
patient. This bill is currently pending in
the Senate Business and Professions
Committee.
FUTURE MEETINGS:





Executive Officer: Darlene Stroup
(916) 920-7466
The Board of Registration for
Professional Engineers and Land
Surveyors (PELS) regulates the practice
of engineering and land surveying
through its administration of the
Professional Engineers Act, sections
6700 through 6799 of the Business and
Professions Code, and the Professional
Land Surveyors' Act, sections 8700
through 8805 of the Business and
Professions Code. The Board's regula-
tions are found in Chapter 5, Title 16 of
the California Code of Regulations
(CCR).
The basic functions of the Board are
to conduct examinations, issue certifi-
cates, registrations, and/or licenses, and
appropriately channel complaints
against registrants/licensees. The Board
is additionally empowered to suspend or
revoke registrations/licenses. The Board
considers the proposed decisions of
administrative law judges who hear
appeals of applicants who are denied a
registration/license, and those who have
had their registration/license suspended
or revoked for violations.
The Board consists of thirteen mem-
bers: seven public members, one
licensed land surveyor, four registered
Practice Act engineers and one Title Act
engineer. Eleven of the members are
appointed by the Governor for four-year
terms which expire on a staggered basis.
One public member is appointed by the
Speaker of the Assembly and one by the
Senate President pro Tempore.
The Board has established four
standing committees and appoints other
special committees as needed. The four
standing committees are Administra-
tion, Enforcement, Examination/
Qualifications, and Legislation. The
committees function in an advisory
capacity unless specifically authorized
to make binding decisions by the Board.
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